Business Context and Reporting Period
This Form 8-K is a current report filed by Hancock Jaffe Laboratories, Inc. (not Envveno Medical Corp) on May 23, 2019. The report addresses a corporate governance event under Item 5.02 regarding the departure of a director and officer.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report on a specific event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the resignation of Yury Zhivilo as a director and Chairman of the Company, effective immediately on May 23, 2019. The filing explicitly states that this resignation is not in connection with any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on future performance. No specific risks or contingencies are disclosed beyond the standard disclosure of the leadership change.
Key Facts for Investor Verification
- Yury Zhivilo resigned as Chairman and Director effective May 23, 2019.
- The resignation is stated to be unrelated to any disagreement with the Company.
- The report was signed by Robert A. Berman, Chief Executive Officer, on May 24, 2019.
- The company trades under the symbol HJLI on The NASDAQ Stock Market LLC.